IL10 and neoplasm: Tumor cells evade immune surveillance by downregulating tumor-associated antigens and major histocompatibility complex molecules, overexpressing immune checkpoint ligands, shedding antigens, and releasing immunosuppressive mediators such as TGF-β, IL-10, and PD-L1, resulting in cytotoxic T lymphocyte exhaustion and tumor persistence.